Hemophilia News TodayDimension to End Development of DTX101 as Gene Therapy for Hemophilia BHemophilia News TodayDimension Therapeutics will discontinue clinical development of DTX101, a gene therapy intended to treat moderate/severe-to-severe hemophil… Continue reading
Stem-cell transplants show limited benefit for double-hit lymphoma patients in remissionScience DailyPatients with double hit lymphoma (DHL) who undergo autologous stem-cell transplantation (autoSCT) after achieving remission are not more likely to rem… Continue reading
|
Lotusland 17: BC’s diverse population needs diverse stem cell donors
Delta-Optimist Held in partnership with Canadian Blood Services, it’s an outreach to the Asian community and those from multi-ethnic or biracial backgrounds to consider becoming a stem cell donor. Matching blood types is relatively easy – matching stem cell and bone … |
|
CardioBreak: All Wrong on Salt; Energy Drinks in Long QT; Gene Therapy Ups and Downs
MedPage Today The investigational allogeneic stem cell therapy CAP-1002 didn’t look good in interim data from the phase II ALLSTAR trial, which showed futility in changing infarct size in patients suffering an MI. (BioPharmaDIVE). Angiogenic gene therapy, XC-001 … |
|
Belgium Steps Further into Immunotherapies – Highlighting Open …
Applied Clinical Trials Online (press release) (registration) (blog) The Belgian health ministry has decreed that Belgian lung-cancer patients can receive and be reimbursed for immunotherapy treatments. |